Alexion gains on rumors of Roche offer
13:46 EDT 3 Aug 2012 | BioCentury
Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) gained $4.66 to $106.96 on Friday after rumors surfaced that Roche (SIX:ROG; OTCQX:RHHBY) made an offer to acquire the biotech for about $128 per share, or about $24.7 billion. Alexion and Roche's Genentech..
Original Article: Alexion gains on rumors of Roche offer
More From BioPortfolio on "Alexion gains on rumors of Roche offer"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
